| Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC) (NCT05374200) | University of Alberta | 2021-10-03 |
| Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) (NCT04956328) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-07-22 |
| A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (NCT04933292) | Xiaoli Fan | 2021-06-16 |
| Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (NCT04604652) | HighTide Biopharma Pty Ltd | 2021-05-27 |
| PBC Induced Fatigue Treated With Thiamine (NCT04893993) | Henning Grønbæk | 2021-05-12 |
| Online Wellness Intervention for Primary Biliary Cholangitis (PBC) (NCT04791527) | University of Alberta | 2021-02-14 |
| A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis (NCT04751188) | Instituto Mexicano del Seguro Social | 2020-10-02 |
| Bezafibrate in Patients With Primary Biliary Cholangitis (PBC) (NCT04514965) | University of Aarhus | 2020-10-01 |
| Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (NCT04526665) | Ipsen | 2020-09-24 |
| A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) (NCT04278820) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-03-20 |
| Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia (NCT04522869) | Vinmec Research Institute of Stem Cell and Gene Technology | 2019-08-10 |
| Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response (NCT03590886) | Sun Yat-sen University | 2018-08-22 |
| Repeatability and Reproducibility of Quantitative MRCP (NCT03809559) | Perspectum | 2018-07-19 |
| Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis (NCT03665519) | National Scientific Medical Center, Kazakhstan | 2018-01-03 |
| Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) (NCT03301506) | Gilead Sciences | 2017-12-12 |
| Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis (NCT03668145) | Xijing Hospital of Digestive Diseases | 2017-11-08 |
| Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis (NCT03112681) | Zydus Therapeutics Inc. | 2017-08-18 |
| Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. (NCT03226067) | Calliditas Therapeutics AB | 2017-06-26 |
| Paternally Inherited Phenotypes in Cholestasis (NCT03337074) | Guy's and St Thomas' NHS Foundation Trust | 2017-02-08 |
| An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects (NCT03082937) | Albireo | 2017-01-31 |
| Biobank for Cholestatic Liver Diseases. (NCT03445585) | Mayo Clinic | 2017-01-01 |
| Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine (NCT03489889) | University of Sao Paulo General Hospital | 2016-12-01 |
| Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) (NCT02955602) | Gilead Sciences | 2016-11-28 |
| Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders (NCT02937012) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2016-10-01 |
| sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis (NCT02924701) | University of Aarhus | 2016-09-01 |
| sCD163 in PBC Patients - Assessment of Treatment Response (NCT02931513) | University of Aarhus | 2016-09-01 |
| Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT (NCT03253276) | University of Aarhus | 2016-05-19 |
| Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis (NCT02823353) | Xijing Hospital of Digestive Diseases | 2016-04-08 |
| Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis (NCT02916290) | Xijing Hospital of Digestive Diseases | 2016-01-01 |
| Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid (NCT02823366) | Xijing Hospital of Digestive Diseases | 2016-01-01 |
| Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid (NCT02916641) | Xijing Hospital of Digestive Diseases | 2016-01-01 |
| Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis (NCT02557360) | Pomeranian Medical University Szczecin | 2015-11-01 |
| Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis (NCT02659696) | Teikyo University | 2015-09-01 |
| An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis (NCT02321306) | Mirum Pharmaceuticals, Inc. | 2015-05-01 |
| Pilot Study of FFP104 Dose Escalation in PBC Subjects (NCT02193360) | Fast Forward Pharmaceuticals | 2015-05-01 |
| Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients (NCT02477462) | University of California, Davis | 2015-05-01 |
| Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis (NCT02078882) | Christopher Bowlus, MD | 2014-09-01 |
| Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis (NCT02135536) | NGM Biopharmaceuticals, Inc | 2014-05-01 |
| Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis (NCT02026401) | NGM Biopharmaceuticals, Inc | 2014-02-01 |
| Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (NCT01904058) | Mirum Pharmaceuticals, Inc. | 2013-08-01 |
| A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 (NCT02963077) | Albireo | 2013-07-01 |
| Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT (NCT01879735) | University of Aarhus | 2013-06-01 |
| B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis (NCT02376335) | Newcastle-upon-Tyne Hospitals NHS Trust | 2012-10-01 |
| Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (NCT01614405) | University of Alberta | 2012-06-01 |
| Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis (NCT01473524) | Intercept Pharmaceuticals | 2012-01-01 |
| Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (NCT01440309) | Robert Chunhua Zhao, MD, PhD | 2011-11-01 |
| Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis (NCT01662973) | Beijing 302 Hospital | 2011-10-01 |
| High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis (NCT01603199) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2011-09-01 |
| A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid (NCT01389973) | Janssen Research & Development, LLC | 2011-09-01 |
| Pentoxifylline for Primary Biliary Cirrhosis (NCT01249092) | The Cleveland Clinic | 2010-11-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis (NCT01857284) | Beijing Friendship Hospital | 2009-09-01 |
| Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) (NCT00746486) | Dr. Falk Pharma GmbH | 2009-02-01 |
| Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis (NCT01510860) | Dr. Falk Pharma GmbH | 2008-11-01 |
| Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis (NCT00587119) | Mayo Clinic | 2007-12-01 |
| Use of Fenofibrate for Primary Biliary Cirrhosis (NCT00575042) | University of Florida | 2007-08-01 |
| Initial Study of Rituximab to Treat Primary Biliary Cirrhosis (NCT00364819) | University of California, Davis | 2007-01-01 |
| Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis (NCT00805805) | George Brewer | 2006-04-01 |
| Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis (NCT00844402) | Medical University of Graz | 2006-01-01 |
| Study of Combivir for Patients With Primary Biliary Cirrhosis (NCT00490620) | University of Alberta | 2004-01-01 |
| Genetic Epidemiology of Primary Biliary Cirrhosis (PBC) (NCT01161953) | Mayo Clinic | 2002-03-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (NCT01430429) | Light Chain Bioscience - Novimmune SA | |